<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Sharad S Malavade | Leila S. Hojat</title><link>https://leilahojat.rbind.io/author/sharad-s-malavade/</link><atom:link href="https://leilahojat.rbind.io/author/sharad-s-malavade/index.xml" rel="self" type="application/rss+xml"/><description>Sharad S Malavade</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Mon, 27 Apr 2020 00:00:00 +0000</lastBuildDate><image><url>https://leilahojat.rbind.io/media/icon_hu56d41535a75a5f294458823b31bc6c45_22384_512x512_fill_lanczos_center_2.png</url><title>Sharad S Malavade</title><link>https://leilahojat.rbind.io/author/sharad-s-malavade/</link></image><item><title>SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis</title><link>https://leilahojat.rbind.io/publication/hcq-in-covid/</link><pubDate>Mon, 27 Apr 2020 00:00:00 +0000</pubDate><guid>https://leilahojat.rbind.io/publication/hcq-in-covid/</guid><description/></item></channel></rss>